Dana-Farber/Mass General Brigham Cancer Care, Inc is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Dana-Farber/Mass General Brigham Cancer Care, Inc has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Hematologic Neoplasms, Multiple Myeloma.
Sponsors: Celgene.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber/Mass General Brigham Cancer Care, Inc has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber/Mass General Brigham Cancer Care, Inc has 2 clinical trials on record, with 1 currently active. Their work covers Hematologic Neoplasms, Multiple Myeloma.
Dana-Farber/Mass General Brigham Cancer Care, Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.